4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-21-065993
Chief Executive Officer acquired 60,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lynch Casey Chief Executive Officer | 2021-11-18 | Option exercise | +60,000 | $0.46 | $27,600 | 109,895 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Lynch Casey Chief Executive Officer | 2021-11-18 | Option exercise · Stock Option (Right to Buy) | −60,000 | 23,159 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…